Drugs / Allogeneic Umbilical Cord Mesenchymal Stem Cell
Allogeneic Umbilical Cord Mesenchymal Stem Cell
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT04876326 Comparator | Oct 2020 → Oct 2021 | multiple system atrophy, parkinsonian type | Indonesia University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Umbilical Cord Mesenchymal Stem Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04876326 ↗ |
| Modality | Cell therapy | “intrathecal implantation of allogeneic mesenchymal stem cells from the umbilical cord” NCT04876326 ↗ |
| Route | Intrathecal | “This group will receive intrathecal implantation of allogeneic mesenchymal stem cells from the umbilical cord with a dose of 2 x 50 million cells given a distance of 1 month.” NCT04876326 ↗ |